Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Peer Review reports

Original Submission
20 Nov 2018	Submitted	Original manuscript
24 Dec 2018	Reviewed	Reviewer Report - Abderrahim Oussalah
16 Jan 2019	Reviewed	Reviewer Report - Francesca Pezzuto
22 Feb 2019	Author responded	Author comments - Chung Ryul Oh
Resubmission - Version 2
22 Feb 2019	Submitted	Manuscript version 2
11 Mar 2019	Author responded	Author comments - Chung Ryul Oh
Resubmission - Version 3
11 Mar 2019	Submitted	Manuscript version 3
Publishing
15 Mar 2019	Editorially accepted
1 Apr 2019	Article published	10.1186/s12885-019-5483-x

Back to article page